[Asia Economy Reporter Hwang Junho] ADM Korea announced on the 11th that it has decided to acquire 72,712 shares (2,483.11 million KRW) of ADM Bioscience through a rights offering (cash acquisition).



The company stated that it undertook this share acquisition to expand its core technology research and development capabilities, actively advance its business, and improve its financial structure.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing